Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis
Authors
Keywords
-
Journal
NATURE GENETICS
Volume 45, Issue 7, Pages 784-790
Publisher
Springer Nature
Online
2013-06-10
DOI
10.1038/ng.2656
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is Passive Diagnosis Enough?
- (2012) David W. Dowdy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis
- (2012) Kathy Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance
- (2012) Aurelia M. Schmalstieg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Beijing Sublineages of Mycobacterium tuberculosis Differ in Pathogenicity in the Guinea Pig
- (2012) Midori Kato-Maeda et al. Clinical and Vaccine Immunology
- Microevolution of extensively drug-resistant tuberculosis in Russia
- (2012) N. Casali et al. GENOME RESEARCH
- Genetic diversity, population structure and drug resistance of Mycobacterium tuberculosis in Peru
- (2012) C.A. Taype et al. INFECTION GENETICS AND EVOLUTION
- New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future
- (2012) Christian Lienhardt et al. JOURNAL OF INFECTIOUS DISEASES
- Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study
- (2012) Timothy M Walker et al. LANCET INFECTIOUS DISEASES
- Bayesian Phylogenetics with BEAUti and the BEAST 1.7
- (2012) Alexei J. Drummond et al. MOLECULAR BIOLOGY AND EVOLUTION
- Spoligotyping and Drug Resistance Analysis of Mycobacterium tuberculosis Strains from National Survey in China
- (2012) Yu Pang et al. PLoS One
- Evaluation of 24-locus MIRU-VNTR in extrapulmonary specimens: Study from a tertiary centre in Mumbai
- (2012) Viral Vadwai et al. TUBERCULOSIS
- Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistantMycobacterium tuberculosisthrough Efflux
- (2011) Gail E. Louw et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
- (2011) Kristin N. Adams et al. CELL
- Totally Drug-Resistant Tuberculosis in India
- (2011) Z. F. Udwadia et al. CLINICAL INFECTIOUS DISEASES
- Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes
- (2011) Iñaki Comas et al. NATURE GENETICS
- Whole-Genome Sequencing and Social-Network Analysis of a Tuberculosis Outbreak
- (2011) Jennifer L. Gardy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phylogeny of Mycobacterium tuberculosis Beijing Strains Constructed from Polymorphisms in Genes Involved in DNA Replication, Recombination and Repair
- (2011) Olga Mestre et al. PLoS One
- Spontaneous Emergence of Multiple Drug Resistance in Tuberculosis before and during Therapy
- (2011) Caroline Colijn et al. PLoS One
- Human Macrophage Responses to Clinical Isolates from the Mycobacterium tuberculosis Complex Discriminate between Ancient and Modern Lineages
- (2011) Damien Portevin et al. PLoS Pathogens
- The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa
- (2010) Thomas R Ioerger et al. BMC GENOMICS
- Strains of the East Asian (W/Beijing) Lineage of Mycobacterium tuberculosis Are DosS/DosT-DosR Two-Component Regulatory System Natural Mutants
- (2010) A. Fallow et al. JOURNAL OF BACTERIOLOGY
- Mixed Infection with Beijing and Non-Beijing Strains and Drug Resistance Pattern ofMycobacterium tuberculosis
- (2010) Han-Yu Huang et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
- (2010) Neel R Gandhi et al. LANCET
- Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved
- (2010) Iñaki Comas et al. NATURE GENETICS
- Tuberculosis Management by Private Practitioners in Mumbai, India: Has Anything Changed in Two Decades?
- (2010) Zarir F. Udwadia et al. PLoS One
- Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli
- (2009) Ali Akbar Velayati et al. CHEST
- Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance
- (2009) Indra L. Bergval et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Lipid Profile Typifies the Beijing Strains ofMycobacterium tuberculosis
- (2009) Gaëlle Huet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapid Detection ofMycobacterium tuberculosisand Rifampin Resistance by Use of On-Demand, Near-Patient Technology
- (2009) Danica Helb et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis
- (2009) Dick Menzies et al. PLOS MEDICINE
- Tuberculosis Drug Resistance Mutation Database
- (2009) Andreas Sandgren et al. PLOS MEDICINE
- Estimating the Per-Base-Pair Mutation Rate in the Yeast Saccharomyces cerevisiae
- (2008) Gregory I. Lang et al. GENETICS
- Progression to Active Tuberculosis, but Not Transmission, Varies byMycobacterium tuberculosisLineage in The Gambia
- (2008) Bouke C. de Jong et al. JOURNAL OF INFECTIOUS DISEASES
- High Functional Diversity in Mycobacterium tuberculosis Driven by Genetic Drift and Human Demography
- (2008) Ruth Hershberg et al. PLOS BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started